When multiple industry mavens and ultra-successful entrepreneurs come together as a “super-group” to form an emerging company, something special happens. Cutting-edge products are made and true innovation can flourish in these circumstances, so sophisticated investors watch for these rare events and position themselves accordingly.
You don’t see this every day because very few new companies can attract top-tier talent with stellar, documented track records of success. Emerging companies might have one bona fide celebrity among their ranks, but having multiple industry luminaries is almost unheard of.
But it does happen from time to time, and I’m constantly on the lookout for these opportunities. Sometimes this occurs in unexpected places, like the cannabis market, but on the other hand, legalized cannabis has been a hotbed of growth and innovation in recent years so perhaps it shouldn’t be surprising that my most recent and exciting discovery is in this lucrative market.
Cannabis has been part of a massive international wellness market that is still in its prime expansion phase. It’s a bold and brilliant move for former Johnson & Johnson Global Chief Transformation Officer Jeff Smith to join the next-generation wellness market superstar The Yield Growth Corp. (CSE: BOSS & US: BOSQF) as a director of its subsidiary Flourish Mushroom Labs Inc.
With worldwide sales of $76 billion , Johnson & Johnson is the world’s largest and most diversified healthcare company. As president of U.S. skincare, Jeff Smith grew it from the third-largest skincare company to number one in the U.S. in just 3.5 years.
Prior to Johnson & Johnson, Mr. Smith worked for Procter & Gamble, and he currently serves on numerous industry boards, including the Board of Directors of the Personal Care Products Council. For an industry shark like Jeff Smith to join a small wellness product company as the Advisory Board Chairman is big news; he clearly sees huge potential in legalized cannabis and The Yield Growth Corp.
Talk about a bold move: Jeff Smith is coming from the likes of Johnson & Johnson and Procter & Gamble to a cutting-edge company with seven subsidiaries, including six cannabis product companies and a medicinal mushroom business known as Flourish Mushroom Labs.
With 200 proprietary cannabis product formulas and a dozen patents pending, plus 145 formulas for edible mushroom products, The Yield Growth Corp. is poised to grow even faster than today’s famous names in cannabis and wellness. They will eventually get into medicinal mushroom products.
At the helm of The Yield Growth Corp. is a serial entrepreneur and a true trailblazer, President and CEO Penny White. A celebrity in her own right, Ms. White has been listed among Profit magazine’s top 100 Canadian female entrepreneurs. Her law firm, Bacchus Law Corporation, was included in Profit’s 500 fastest-growing companies in 2015 and 2016 based on revenues.
With extensive experience in capital markets and over 100 private-to-public transactions, Penny White co-founded Merus Labs Inc., which had revenues of $111 million in fiscal 2016 and was sold to Norgine B.V. in July 2017 for around $342 million.
She’s been an attorney and a rainmaker in multiple industries, and Ms. White knows how to assemble an unbeatable team. Getting Jeff Smith on the board of The Yield Growth Corp. subsidiary Flourish Mushroom Labswas a major coup, as he’ll leverage his years of experience and expertise to provide enhanced shareholder value for BOSS/BOSQF investors.
This is worth a careful look with The Yield Growth’s super-group of marketing, retail, and wellness product experts on board. Ms. White truly has the best team in the business, and with a track record like this, you just can’t go wrong.
Get updates on The Yield Growth Corp. and
more Wealth Building Ideas for the new economy.
No matter how good an investment sounds, and no matter who is selling it, make sure you’re dealing with a registered investment professional. Use the free, simple search at investor.gov
This work is based on public filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Never base any decision off of our advertorials. Wallace Hill LTD (WealthResearchGroup.com) stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEDAR filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with SEDAR under the company’s profile, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have been compensated by The Yield Growth four hundred and fifty thousand dollars for an active digital marketing agreement. We could be paid up to an additional four hundred and fifty thousand dollars in three quarterly payments of one hundred a fifty thousand. We have also recently participated in a private placement and own shares of the company with a four month hold on other trading restrictions. We will not sell shares within thirty days of any email coverage. We will never sell any shares during any active email coverage. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at wealthresearchgroup.com/disclaimer